Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 19, 2026

Stock market today: Dow, S&P 500, Nasdaq turn lower with oil prices, Walmart, rate-cut bets in focus

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq turn lower with oil prices, Walmart, rate-cut bets in focus US stocks turned firmly into the red on Thursday as US-Iran fears spurred a continued rally in oil, with Walmart (WMT) earnings and Federal Reserve rate-cut odds in focus…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Trump administration is edging toward military conflict with Iran

    80% confidence
  • US has largest air power armament in Middle East since invasion of Iraq in 2003

    80% confidence
  • Samsung is negotiating price for HBM4 at around $700 per unit, up to 30% higher than previous generation

    80% confidence
  • Talks between Tehran and Washington had reached a potential framework for a deal on Iran's nuclear program

    80% confidence
  • DoorDash expects marketplace GOV to be in range of $31.0 billion to $31.8 billion for Q1 2026

    80% confidence
  • SK Hynix set price of HBM4 for Nvidia in mid-$500 range in August but may move to match Samsung's higher number

    80% confidence
  • DoorDash expects adjusted EBITDA to be in range of $675 million to $775 million for Q1 2026

    80% confidence
  • Walmart faces headwinds including tariffs, geopolitical conditions, and inflation in year ahead

    80% confidence

Data points we hold from this source

Board of Governors of the Federal Reserve System · interest rate target range low3.5 percent
Board of Governors of the Federal Reserve System · interest rate target range high3.75 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
Stock market today: Dow, S&P 500, Nasdaq turn lower with oil prices, Walmart, rate-cut bets in focus — Source | Via News | Via News